NCT06364670 Application of Machine Learning Based on fNIRS in Predicting Acupuncture's Efficacy in Treating Tinnitus
| NCT ID | NCT06364670 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University |
| Condition | Tinnitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-05 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2024-05 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial aims to use machine learning to analyze fNIRS imaging data of specific brain regions of tinnitus patients, thereby constructing a predictive model of the clinical efficacy of acupuncture for SNT.
Eligibility Criteria
Inclusion Criteria: * Bilateral tinnitus that meets the diagnostic criteria for chronic subjective tinnitus. * Male and female, aged between 18 and 60 years. * Right-handed subjects who are able to comply with the study protocol and sign written informed consent. * Not participating in other clinical trials concurrently. Exclusion Criteria: * Participants with objective tinnitus. * Participants have nervous system diseases or neuropsychiatric diseases that can significantly affect brain blood oxygen metabolism assessed by fNIRS. * Participants with severe cardiovascular and cerebrovascular diseases, malignant liver and kidney diseases, and other serious diseases. * Participants have any contraindications for acupuncture (such as a bleeding tendency). * Pregnant or lactating women. * Participants have received tinnitus treatment with drugs or other therapies in the last four weeks.
Contact & Investigator
Hantong Hu, M.D
PRINCIPAL INVESTIGATOR
The Third Affiliated hospital of Zhejiang Chinese Medical University
Frequently Asked Questions
Who can join the NCT06364670 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06364670 currently recruiting?
Yes, NCT06364670 is actively recruiting participants. Contact the research team at 1215360683@qq.com for enrollment information.
Where is the NCT06364670 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06364670 clinical trial?
NCT06364670 is sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University. The principal investigator is Hantong Hu, M.D at The Third Affiliated hospital of Zhejiang Chinese Medical University. The trial plans to enroll 500 participants.